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The NewWorld arenavirus Junin (JUNV) is the etiological agent of Argentine hemorrhagic
fever (AHF). Previous studies of human macrophage infection by the Old-World
arenaviruses Mopeia and Lassa showed that while the non-pathogenic Mopeia virus
replicates and activates human macrophages, the pathogenic Lassa virus replicates but
fails to activate human macrophages. Less is known in regard to the impact of New
World arenavirus infection on the human macrophage immune response. Macrophage
activation is critical for controlling infections but could also be usurped favoring immune
evasion. Therefore, it is crucial to understand how the JUNV infection modulates
macrophage plasticity to clarify its role in AHF pathogenesis. With this aim in mind, we
compared infection with the attenuated Candid 1 (C#1) or the pathogenic P strains of the
JUNV virus in human macrophage cultures. The results showed that both JUNV strains
similarly replicated and induced morphological changes as early as 1 day post-infection.
However, both strains differentially induced the expression of CD71, the receptor for cell
entry, the activation and maturation molecules CD80, CD86, and HLA-DR and selectively
modulated cytokine production. Higher levels of TNF-α, IL-10, and IL-12 were detected
with C#1 strain, while the P strain induced only higher levels of IL-6. We also found that
C#1 strain infection skewed macrophage polarization to M1, whereas the P strain shifted
the response to an M2 phenotype. Interestingly, the MERTK receptor, that negatively
regulates the immune response, was down-regulated by C#1 strain and up-regulated
by P strain infection. Similarly, the target genes of MERTK activation, the cytokine
suppressors SOCS1 and SOCS3, were also increased after P strain infection, in addition
to IRF-1, that regulates type I IFN levels, which were higher with C#1 compared with P
strain infection. Together, this differential activation/polarization pattern of macrophages
elicited by P strain suggests a more evasive immune response and may have important
implications in the pathogenesis of AHF and underpinning the development of new
potential therapeutic strategies.
Keywords: junin virus, human macrophages, TAM receptors, macrophage activation, macrophage polarization,
IFN-I
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INTRODUCTION
Junin virus (JUNV) is the etiological agent of Argentine
hemorrhagic fever (AHF), an endemoepidemic disease mainly
affecting agricultural workers in Argentina. The infection is
usually acquired through small abrasions in the skin or through
aspiration of particles contaminated with urine, saliva, or blood
from carrier rodents. The AHF incubation period ranges from 6
to 12 days, ending with the onset of fever. During first 7 days,
patients are commonly associated with a flu-like syndrome and
the fever persists until the second week, when hemorrhagic or
neurological signs of varied severity may be present. The 80% of
patients improve after the second week. AHF diagnosis is based
on clinical and laboratory data, the latter mainly based on platelet
counts below 100,000/mm3 in combination with white blood cell
counts under 2,500/mm3. Early diagnosis is important, because
the early use of immune plasma from convalescent patients
reduces mortality rates from 20 to 1%. Candid #1 (C#1) is a live
attenuated vaccine against AHF, which is licensed in Argentina
and has been administered to several hundred thousand persons
in endemic areas for more than 20 years, with a major impact on
the incidence of the disease. However, since the first description
of the disease in the 1950s, uninterrupted annual outbreaks
have been observed in a progressively expanding region in
north-central Argentina, to the point that more than 5 million
individuals are today considered to be at risk of AHF (1).
JUNV belongs to the clade B New World (NW) of genus
mammarenavirus that together with genus reptarenavirus
form the Arenaviridae family (2). Most mammarenavirus
are associated with rodent infections. The Old World (OW)
choriomeningitis lymphocytic virus (LCMV) infects Mus
musculus, and this explains its global distribution. In contrast,
other strains of mammarenavirus infect rodents with a
circumscribed geographical distribution that explains their
endemicity (3). In their natural rodent host, mammarenavirus
usually produce a persistent asymptomatic infection that may
occasionally be transmitted to humans where it can cause severe
hemorrhagic fever (HF). In addition to JUNV, other strains of
mammarenavirus associated with HF are the NW Machupo
(MACV) and Chapare (CHPV) viruses in Bolivia, Sabiá (SABV)
in Brazil and the OW Lassa virus (LASV) in Africa. In contrast,
other members such as the NW Tacaribe (TCRV) and Pichindé
(PICV) or the OWMopeia (MOPV) viruses do not cause disease
(4). The mammarenavirus are etiological agents of emergent
diseases because human activity facilitates contact with wild
rodents in new ecological niches and, therefore, new isolates
should be expected in the future (3).
Like other members of the same family, JUNVs are enveloped
virions, ∼120 nm in diameter, with a capsid of helicoidal
symmetry that includes a variable number of ribosomes. The
virions contain a bi-segmented single-stranded RNA genome,
with both segments employing an ambisense coding strategy. The
L segment contains genes encoding the RNA-dependent RNA
polymerase (L) and the matrix protein (Z). However, the smaller
S segment encodes the nucleoprotein (N) and the glycoprotein
precursor (GPC) which, after post-translational cleavage, yields
mature virion glycoproteins (G) G1, G2 and the stable signal
peptide SSP that together will constitute the spikes that decorate
the virus surface (5).
Macrophages are the most functionally diverse (plastic) cells
of the hematopoietic system.Macrophages are found in all tissues
and their main function is to respond to pathogens and modulate
the adaptive immune response through antigen processing and
presentation (6, 7). Macrophage activation has emerged as a
key area of study in immunology, tissue homeostasis, disease
pathogenesis and inflammation resolution (8). To accomplish
such diverse functions, they mature under the influence of
signals from the local microenvironment into either classical
M1 or alternatively M2 activated macrophages. M1 macrophages
are characterized by the production of high levels of pro-
inflammatory cytokines, an ability to mediate resistance to
pathogens, strong microbicidal properties, high production of
reactive nitrogen and oxygen intermediates and promotion
of Th1 responses. In contrast, M2 activated macrophages are
characterized by their involvement in parasite control, resolution
of inflammation, tissue remodeling, immune regulation, and Th2
promotion responses (6, 9).
In this study, we aimed to characterize the infection of
macrophages using two strains of the same arenavirus with
different pathogenic properties. For this purpose, we studied the
infection of human macrophages by the attenuated C#1 and the
pathogenic P strains of JUNV, using an in vitromodel represented
by human macrophage cell cultures.
MATERIALS AND METHODS
Cells
BHK-21 and Vero-76 cells (ATCC, USA) were maintained
as monolayers, as previously described (10). Peripheral blood
mononuclear cells (PBMCs) were obtained from healthy
volunteer donors who had not taken any non-steroidal anti-
inflammatory drugs for 10 days prior to sampling as previously
described (11). This study was approved by the Institutional
Ethics Committee, National Academy of Medicine, Argentina.
Written consent was obtained from all subjects. Human
monocyte-derived macrophages (HMDM) were obtained as
previously reported (12). Briefly, PBMCs from healthy donors
were isolated by Ficoll-Hypaque (GE, Chicago, IL, USA)
density gradient centrifugation, and positive selection of CD14+
monocytes was performed using an EasySep
TM
Human CD14
Positive Selection Kit (StemCell Tech, Vancouver, Canada).
Macrophage differentiation was carried out by plating 2.5
× 105 CD14+ monocytes in 48-well plates containing 500
µL of RPMI 1640 plus 10% Fetal Bovine Serum (FBS) and
1% penicillin/streptomycin (PS) in the presence of rM-CSF
(40 ng/ml) and cultured for 7 days. In selected experiments, 24-
well plates were used with a double quantity of cells and medium.
Virus
A virulent strain of JUNV, originally isolated from an AHF
patient (P3441), as well as the attenuated Candid 1 (C#1) have
been already described (13). The preparation of viral stocks in
BHK-21 cells and infectivity titration using the Vero-76 cell line
Frontiers in Immunology | www.frontiersin.org 2 October 2019 | Volume 10 | Article 2499
Ferrer et al. Arenavirus Modulates Macrophage Polarization
has been previously described (13). All work with the infective P
strain was performed in a BSL/3 facility by vaccinated personal.
Reagents
MEM, RPMI, and FBS were purchased from Invitrogen (Buenos
Aires, Argentina). rM-CSF was acquired from R&D Systems
(Minneapolis, MN, USA). Anti JUNV antibodies were obtained
from BEI resources, USA. Anti CD71, CD14, CD86, CD80,
HLA-DR, CD11b, CD11c, CD64, CD163, CD206 were obtained
from BioLegend (San Diego, CA, USA). Anti-human APC-
MERTK (mouse IgG1), Biotin-AXL (goat IgG) and isotype
controls were obtained from R&D Systems (Minneapolis, MN,
USA). Anti-TYRO3 (rabbit IgG) was obtained from Novus
Biological (Littleton, CO, USA). DAPI was purchased from
Invitrogen (Buenos Aires, Argentina). ELISA kits (Ready-SET-
Go kits) for TNF-α, IL-1β, IL-6, IL-10, and IL-12p70 were
obtained from eBioscience, Fisher scientific, Pittsburgh, PA, USA.
Cytofix/Cytoperm kit was purchased from BD Bioscience (San
Diego, CA, USA).
Cell Infection
For viral infection, cells were washed with PBS twice before
incubating with the virus at a multiplicity of infection (MOI)
of 1 in serum free medium. After 1 h of incubation at 37◦C,
cells were washed with PBS twice again and supplemented with
a complete culture medium. Mock infection was performed by
adding the same volume of BHK-21 cell culture supernatant,
instead of JUNV, to the cell monolayer. Cells were observed daily
using an inverted microscope with an Olympus SP-320 camera
and images were further processed with Photoshop 6.0 software.
Plaque Formation Assay
Ten-fold dilutions of the macrophage-JUNV infected culture
supernatants were added to 24-well plates with a 40–50%
confluence monolayer of Vero E6 cells. The plate was then
incubated at 37◦C for 1 h with gentle rocking. Following
adsorption, the inoculum was removed and overlaid with 2ml of
MEM containing 0.8% methylcellulose and 2% FBS and further
incubated at 37◦C in a humid atmosphere with 5% CO2. Plaques
were allowed to develop for either 4–6 days before being fixed
(4% w/v paraformaldehyde) and stained with a 1% Crystal Violet
in 20% ethanol and dH2O.
Indirect Immunofluorescence Studies
Cells were cultured on 12mm diameter glass inserts before viral
infection. At the indicated time-point after infection, the inserts
were fixed with 4% paraformaldehyde (PFA) for 20min and
permeabilized with 0.1% Tween for 10min. The slides were
incubated overnight at 4◦C with a pool of specific monoclonal
antibodies against JUNV (13). FITC-conjugated anti mouse Igs
were then applied to the PBS-washed slides for 30min at room
temperature (RT). Antibodies were diluted with PBS containing
5% FBS and 5% goat serum as blocking reagents. The slides
were counterstained with DAPI and examined under a Nikon
E200 microscope equipped with fluorescence filters and a 100-
W mercury lamp. Images were acquired with a Tucsen TCC 5.0
refrigerated camera under the control of IS listen software and
further processed using Photoshop 6.0 software.
Flow Cytometry Analysis
The viability assay on macrophages culture was performed after
72 h of JUNV infection using Annexin V (AnnV) (Immunotools,
Gladiolenweg, Friesoythe, Gemany) together with Fixable
viability dye (eBioscience, USA). Briefly, cell harvesting was
performed by a 20-min incubation with PBS plus 2% FBS (PBSF)
and 1mM EDTA on ice, followed by up and down pipetting. The
harvested cells were washed once with PBSF and then stained
with fixable viability dye efluor 780 diluted in PBS for 30min.
After washing cells, they were stained with AnnV following
manufacturer’s instruction. After final washing, the cells were
fixed with a Cytofix/Cytoperm Kit (BD Biosciences, USA).
The surface staining for CD11b, CD64, CD206, CD14
(phenotypic characterization of macrophages) or CD11b, HLA-
DR, CD86, and CD80 (activation status) was performed
following a standard protocol. Briefly, the harvested cells were
washed with PBS and blocked in PBSF on ice for 30min.
The cells were washed with PBS and the respective antibody
cocktails (prepared in PBSF) were added to the cell pellet and
incubated for 30min on ice. A fixable viability dye was used
according to the manufacturer’s instructions to gate on live cells.
After washing, the cells were fixed with a Cytofix/Cytoperm
Kit, washed again and analyzed in a FACS Canto I (Becton
Dickinson, Franklin Lakes, NJ, USA) or Partec-Sysmex CyFlow
flow cytometer (Görlitz, Germany). All analysis was carried
out with FlowJo software (Tree Star). Intracellular staining was
performed following manufacturer’s recommendation for the
Cytofix/Cytoperm Kit. The preparation of blockage and cocktail
antibodies was performed with PBSF. We have used fluorescent
minus one (FMO) to set the threshold for each marker.
Enzyme Linked Immunosorbent Assay
(ELISA)
IL-6, IL-12p70, TNF-α, and IL-10 levels were assessed in culture
supernatants with ELISA Ready-SET-Go kits (e-Bioscience)
according to the manufacturer’s protocol.
RNA Isolation, RT-PCR, and Real-Time
PCR
For gene expression analysis, cultured cells were washed and
then harvested with Trizol (Life Technologies, Carlsbad, CA,
USA) and total RNA was obtained following the manufacturer’s
instructions. Reverse transcription was performed using 100 ng
of RNA by employing an iScript cDNA synthesis kit (Bio-Rad,
Hercules, CA, USA). qPCR reactions were assessed using 1 µl
of cDNA and using Sso Advanced Universal mix with Sybr
Green and CFX-Connect equipment (Bio-Rad). Primers used in
this study are listed in Table S1. The reaction was normalized
to housekeeping gene expression levels and the specificity
of the amplified products was checked through analysis of
dissociation curves.
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Statistical Analysis
Each experiment was performed with 3–7 different donors. All
results are graphed as the median (min-max, horizontal line
indicates the median) and non-parametric one-way analysis
of variance (ANOVA) (Kruskal–Wallis) followed by Dunn’s
multiple comparison test was used to detect significant
differences between groups. In all cases, P-values lower than 0.05
were considered statistically significant. All statistical analyses
were performed using Prism 6 software (GraphPad).
RESULTS
JUNV Strains Replicate Similarly in Human
Macrophages
Human monocyte-derived macrophages (HMDM) cells were
infected at a multiplicity of infection (MOI) = 1 with the
attenuated C#1 or the pathogenic P strains of JUNV. HMDM
cells showed clear morphological changes, such as becoming
more flattened and extended, as early as 24 h post-infection (hpi)
with both JUNV strains (Figure 1A). Infectious virus released to
the cell culture supernatants weremeasured over 6 days by plaque
formation assay. Infection with both viral strains led to similar
levels of infectious viruses, peaking at 3 days post-infection
(dpi) and declining until the end of the study (Figure 1B). Viral
antigen was studied at 3 dpi by immunofluorescence (IF) and
flow cytometry (FC) analysis. Viral protein staining was similarly
positive with both strains (Figure 1C). As expected, FC analysis
confirmed these results showing that 58% of HMDM cells were
infected with C#1 strain meanwhile 57.6% were positive for the P
strain (Figure 1D).
JUNV Strains Differentially Enhances the
Expression of CD71
Viruses exploit fundamental cellular processes to gain entry into
cells and deliver their genetic cargo. Virus entry pathways are
largely defined by the interactions between virus particles and
their receptors at the cell surface. These interactions determine
the mechanisms of virus attachment and, ultimately, penetration
into the cytosol. In contrast to LASV and other OW arenaviruses,
which use α-dystroglycan to infect cells, the NW arenaviruses,
including JUNV, use human transferrin receptor 1 (hTFR1 or
CD71) (14). We have previously shown that JUNV infection
enhances the expression of hTFR1 in the precursor CD34+ cells,
suggesting that JUNV infection promotes its own dissemination
(15). Compared with other cell types, mature macrophages may
be atypical regarding the requirements for hTFR1 expression
levels (16), and for that reason, we explored the expression
pattern in HMDM infected cells. In this sense, our results showed
that JUNV infection enhances CD71 expression in human
macrophages, but with the highest value associated with P strain
infection (Figures 2A–C).
JUNV Strains Differentially Activate
Macrophages and Cytokine Production
We have analyzed the expression pattern of co-stimulatory
markers such as CD80 and CD86, and the antigen presentation
surface marker (HLA-DR). Our results indicate a differential
expression when infected with one or other viral strain. A
significantly higher percentage of CD14+CD86+ cells were
observed after C#1 strain infection, while CD80 did not show
significant differences between infected cells. On the other hand,
P strain-infected macrophages showed the highest percentage
of CD14+ HLA-DR++ cells revealing a differential expression
pattern after infection with C#1 or P strain (Figures 3A,B).
Considering the observed macrophage activation induced by
JUNV infection, we next analyzed the level of several cytokines in
the supernatants of HMDM at 3 dpi. We found a clear distinctive
profile, since higher levels of TNF-α, IL-10, and IL-12 were
detected in the supernatants of C#1 strain-infected macrophages,
but only IL-6 was significantly increased using the P strain.
Interestingly, no difference in IL-1 production was observed
compared with mock conditions, suggesting no activation of
the inflammasome pathway (Figures 3C–G). The percentage of
viable cells does not showed significant differences comparing
Mock, C#1 and P (90.2, 88.25, and 83.5, respectively) although
small increase in AnnV+ cells were observed with P when
compared to C#1 and Mock (Supplementary Information S1).
JUNV Selectively Skews Macrophage
Polarization
Taking into account the fact that JUNV modulates macrophage
activation depending on which strain was used, we next evaluated
different surface markers to distinguish M1/M2 polarization
in HMDM after JUNV infection. The percentage of CD64+
(M1), CD206+, and CD163+ (M2) cells expressed in CD11b+
cells were analyzed by flow cytometry. CD11b+CD64+CD206−
cells were increased when cells were infected with C#1 strain
as compared to Mock and the P strain with an average
of 18 vs. 8% and 3.2%, respectively. However, the M2
phenotype CD11b+CD206+CD64− was significantly higher
after P infection as compared C#1 strain or to Mock with
an average of 34 vs. 10.1%, and 17.5%, respectively. This
indicates that JUNV modulates polarization according to viral
strain pathogenicity (Figures 4A,B). Additionally, another M2
phenotype analyzed as a double positive, CD206+/CD163+
cells, showed a clear tendency toward an increased percentage
after infection with P strain as compared to Mock and C#1
strain infection (44.2 vs. 29.9% and 33.9%, respectively, see
Supplementary Information S2).
The Expression of MERTK Was
Differentially Modulated With JUNV
Variants
The TAM family tyrosine kinase receptors TYRO3, AXL,
and MERTK (TAM) receptors have been assigned to have a
prominent role in the following: regulating the innate immune
response (17); phagocytosis and macrophage polarization by
acting in coordination with cytokine signaling (18); and in
several aspects of the host response to viral infection (19, 20).
Considering our observation that JUNV modulates macrophage
polarization and that AXL and MERTK are differentially
expressed in pro-inflammatory M1 and anti-inflammatory
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FIGURE 1 | Human macrophages are equally susceptible to both JUNV variants. Human monocyte-derived macrophages (HMDM) cells were infected at a multiplicity
of infection (MOI = 1) with the attenuated C#1 or the pathogenic P strains of JUNV. (A) Morphological observation of the cells. JUNV-infected cells become more
flattened and extended. (B) Infective titration of cell supernatants was performed in Vero cells for 6 days by a standard PFU method. (C) Viral antigens were detected
by immunofluorescence with a pool of antibodies and anti-JUNV-FITC, and nuclei were counterstained with DAPI. (D) HMDM cells were infected with C#1 or P strains
and at 3 dpi cells were stained with anti-JUNV-FITC and the percentage of viral antigen positive cells were analyzed by flow cytometry. The percentage of infected
cells was compared using the Non-parametric One-way ANOVA followed by Dunn’s multiple comparison test. The results are graphed as the median (min-max,
horizontal line indicates the median). At least three independent donors were used in each assay.
M2 macrophages, respectively (21), we next evaluated TAM
expression in HMDM after infection with both strains. Our
results showed that while TYRO3+ or AXL+ macrophages
showed a similar response to infection with the two strains,
the percentage of MERTK+ cells was down-regulated by C#1
strain and up-regulated by P strain infection, highlighting again
a differential macrophage response depending on virus strain
(Figures 5A,B).
Since activation of MERTK triggers the induction of the
suppressor of cytokine signaling 1 (SOCS1) and SOCS3, we next
analyzed the transcription level of these genes by RT-qPCR. We
also analyzed interferon regulatory factor 1 (IRF-1) as a target
gene of infection and a member of the interferon regulatory
factor family (22). As expected, we observed higher transcription
levels of IRF-1, SOCS1, and SOCS3 concomitant with lower levels
of IFN-β in macrophages infected with P strain as compared with
mock conditions after 24 hpi (Figures 6A–D).
DISCUSSION
In the present study, we showed that both attenuated C#1
and pathogenic P JUNV strains induced a phenotypic change
in primary human macrophages as early as 1 dpi, that
was interpreted as macrophage maturation and/or activation.
In addition, we observed similar infectivity titers in the
supernatants and a comparable percentage of infected monolayer
cells. This stands in contrast with the reported minimal
replication of JUNV-XJ (pathogenic) and XJ-Cl3 (attenuated)
strains in macrophage cells from adult rats (23), a fact that
may be attributed that macrophages were from a different
donor species.
Previous studies of human macrophage infection by
mammarenavirus have been shown that the non-pathogenic
MOPV both replicates and activates macrophages (24) whereas
pathogenic LASV replicates, but fails to activate macrophages
(25). The lack of activation of LASV-infected macrophages was
later associated with sequence differences in viral protein N
(26) and involved CXCL10 (27). On the other hand, it has been
reported that the non-pathogenic TCRV replicates less efficiently
in macrophages than the pathogenic JUNV, but induces a
cytokine release not observed in JUNV-infected cells (28). More
recently, a differential inhibition of macrophage activation by
LCMV and PICV, mediated by the N-terminal domain (NTD)
of viral Z protein, has been reported (29). Moreover, LCMV
Z NTD leads to increased viral replication and inhibition of
IFN responses in macrophages (30), a fact that has been more
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FIGURE 2 | JUNV enhances CD71 expression in human macrophages with P showing the highest values. HMDM cells were infected at a multiplicity of infection (MOI
= 1) with C#1 or P strains of JUNV. After 3 dpi, cells were double stained with anti-JUNV and anti-CD71 and analyzed by flow cytometry. (A) Representative dot-plots
showing positive signal for viral antigen in macrophages. (B) Representative histogram showing CD71 expression after gating in positive cells for JUNV antigen and
negative controls. (C) Expression level of CD71 analyzed as mean fluorescent intensity (MFI) in graph. Non-parametric One-way ANOVA followed by Dunn’s multiple
comparison test was used to detect significant differences between groups; *P < 0.05. The results are graphed as the median (min-max, horizontal line indicates the
median) of at least four independent donors in each assay.
recently assigned to the Z protein from pathogenic arenaviruses
only (31).
Our results partially support to the hypothesis that OW and
NW arenaviruses may have different pathogenic mechanisms, at
least in macrophages cells (4, 32).
We have previously shown that JUNV infection up-regulates
TfR1 in CD34+ hematopoietic stem cells (15). Here, we
show that both JUNV strains also increased the expression
of CD71 in infected HMDM, with P showing higher values.
This supports the hypothesis that JUNV promotes its own
dissemination not only in undifferentiated hematopoietic cells
but also in a differentiated lineage and that P exploits this
mechanism more.
The observed differential maturation and activation markers
and the cytokine expression profile depending on which JUNV
strain infects the macrophages strongly support the notion
that C#1 and P strains are able to elicit differential immune
responses. In this sense, a higher level of pro-inflammatory
cytokines (IL-12 and TNF-α) together with an increased level
of a co-stimulatory marker (CD86) demonstrates the ability of
the C#1 strain to mount an adequate inflammatory response.
This allows the generation of protective immunity against the
virus in the absence of disease in the host. By contrast, the
pathogenic P strain elicits a more attenuated activation state of
macrophages by decreasing the prototypical pro-inflammatory
cytokines. However, it also remarkably induces higher levels of
IL-6, a cytokine also associated with immunomodulation (33),
and increases the percentage of CD14+HLA-DR++, two signals
that indicate an anti-inflammatory response that might allow
early immune evasion, facilitating viral dissemination in the host
and subsequent disease.
It has been demonstrated that most of the acute viral
infections of pathogenic viruses are associated with macrophage
activation to a M1 status promoting inflammation (34).
Regarding M2, the first studies were carried out with viruses
associated with chronic infections, and the first accepted
paradigmwas that viral infection activates macrophages inducing
a M1 profile during the acute phase and an M2 profile
emerged during the eventual chronic phase of the disease (34,
35). In many of these studies, the M2-prone response related
to an enhanced production of IL-10, which indirectly exerts
potent immunosuppressive effects (36–38). Moreover, some
viruses, such as herpesviruses and poxviruses, encode functional
orthologs of IL-10 (vIL-10s) (39) or IL-6 (33). The viral IL-6 could
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FIGURE 3 | JUNV activates human macrophages and selectively modulates cytokine production. HMDM cells were infected with C#1 or P strains of JUNV (MOI =1)
and at 3 dpi the activation and co-stimulation CD80, CD86, or antigen presentation HLA-DR expression were evaluated in CD14+ cells by flow cytometry. (A)
Representative dot-plots showing CD14+ and each marker are shown. (B) The percentage of double positive CD14+CD86+, CD14+CD80+, and
(Continued)
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FIGURE 3 | CD14+HLA-DR++ are graphed. We had set the threshold for each marker based on the FMO. The expression level of TNF-α and IL-1β (C), IL-12 (D),
IL-10 (E), IL-6 (F), and IL-1β (G) were measured in the supernatant of infected macrophages after 72 h, employing commercial ELISA kits. Non-parametric One-way
ANOVA followed by Dunn’s multiple comparison test was used to detect significant differences between groups, *P < 0.05, **P < 0.01. The results are graphed as the
median (min-max, horizontal line indicates the median) of at least four independent donors in each assay.
FIGURE 4 | JUNV modulates macrophage M1/M2 polarization. HMDM cells were infected with C#1 or P strains of JUNV (MOI =1) and at 3 dpi the cells expressing
CD64+ (M1) and CD206+ (M2) on CD11b+ were evaluated by flow cytometry. (A) Representative dot-plots of CD64 vs. CD206 after gating in CD11b of each
condition are shown. (B) Independent data are graphed showing a shift to M1 after C#1 infection and to M2 after P infection. Non-parametric One-way ANOVA
followed by Dunn’s multiple comparison test was used to detect significant differences between groups; *P < 0.05. The results are graphed as the median (min-max,
horizontal line indicates the median) of five independent donors. We had set the quadrant threshold based on the FMO of each marker.
also inhibit antiviral immunity through inhibition of type I IFN,
which allows HHV8 to evade immune detection (40).
Our results clearly show a potent pro-inflammatory response
was elicited when macrophages were infected with C#1 strain,
concordant with a M1 phenotype. However, the P strain elicited
a more anti-inflammatory M2 response, associated with a higher
level of IL-6, but not IL-10, an increase in CD11b+CD206+
and HLA-DR cell expression suggesting that the P strain shifts
the macrophage response to a regulatory program (41). In
macrophages, IL-10 as well as pro-inflammatory cytokines (TNF-
α, IL-12 and IL-6) are produced in response to activation of
TLRs 2, 3, 4, 7, and 9, via MyD88 or TRIF, NF-kB, and MAPK
pathways (42). The strain P did not stimulate the production of
IL-10 neither pro-inflammatory ones such as IL-12 or TNF-α,
instead of that, a large amount of IL-6, a cytokine also associated
with immunomodulation, was specifically induced by P and
not by C#1 strain. Interestingly, in a different model, the IL-6
cytokine has recently been associated with the promotion of the
M2 phenotype (43) and described as a potent inducer of SOCS3
(33). Furthermore, the generation of human immunosuppressive
myeloid cell populations in human IL-6 transgenic NOG mice
has been demonstrated (44).
Very little is known about M2 macrophage polarization
during acute viral infection since the early anti-viral response is
normally associated with a pro-inflammatory immune response
(45). In this regard, a recently transcriptomic analysis of
macrophages infected with attenuated or virulent influenza virus
strains showed an early and clear profile of genes associated with
the M2 phenotype triggered by a pathogenic influenza virus (46).
It has been shown that AXL and MERTK receptors are
differentially modulated in cytokine-induced M1 and M2
macrophages, where enhanced levels of MERTK were associated
with M2 polarization (21). IRF-1 was initially described as a
regulator of type I IFN and MHC-I expression by binding to
regulatory regions of their promoters (47). However, IRF-1 is
one of the most important IFN-stimulated genes for innate and
adaptive antiviral immunity, making a complex network with
other transcription factors to finally have a specific response
(48–50). In this sense, IRF-2 and 8 can both inhibit IRF-1–
mediated induction of transcription competing by promoter
binding sites (51, 52), or by blocking protein:protein interactions
(53, 54), supporting the hypothesis that viruses can manipulate
the induction of IFN and ISGs to enhance their replication.
In this sense, the selective modulation of the MERTK, as
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FIGURE 5 | JUNV selectively modulates TAM expression in human macrophages. HMDM cells were infected with C#1 or P strains of JUNV (MOI =1) and at 3 dpi the
expression level of TYRO3, AXL, and MERTK receptors was evaluated by flow cytometry. (A) Representative dot plot of each receptor is shown and the percentage of
macrophages expressing TYRO3, AXL, and MERTK receptors are graphed in (B). Non-parametric One-way ANOVA followed by Dunn’s multiple comparison test was
(Continued)
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FIGURE 5 | Used to detect significant differences between groups; **P < 0.01. The results are graphed as the median (min-max, horizontal line indicates the median)
of seven independent donors. We had set the threshold based on the FMO of each receptor.
FIGURE 6 | JUNV P enhances transcription levels of IRF-1, IFN-β, SOCS1, and SOCS3. HMDM cells were infected with C#1 or P strains of JUNV (MOI =1) and after
1 dpi the transcription levels of (A) IRF-1, (B) SOCS1, (C) SOCS3, and (D) IFN-β, were studied by RT-qPCR. The Comparative Ct method (2−1CT ) was used to
analyze the expression level of the target genes. Non-parametric One-way ANOVA followed by Dunn’s multiple comparison test was used to detect significant
differences between groups; *P < 0.05. The results are graphed as the median (min-max, horizontal line indicates the median) of five independent donors.
well as higher levels of IRF-1, SOCS1, and SOCS3 during P
strain infection highlight not only the skewing property of
this strain, but also its ability to usurp immunomodulatory
pathways (TAM/SOCS1 and 3) and potentially use them for
immune evasion.
Our results show that JUNV triggers differential macrophage
activation and modulates polarization according to viral strain
pathogenicity, inducing distinct cell responses that might
facilitate correct immune surveillance or viral evasion and
dissemination events that end in disease. Thus, the results
provide important mechanistic insights into the understanding
of JUNV pathogenesis and the multi-faceted host immune
responses in arenavirus infection.
Taking our results together with the above-mentioned recent
findings by others, it may be speculated that in some acute
viral infections, subversion of the conventional M1 pro-
inflammatory response to a M2 anti-inflammatory response by
acute pathogenic viruses will be more frequent than previously
described, and thus is deserving of further study since this
may allow the development of potential new candidates for
therapeutic targets.
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